封面
市场调查报告书
商品编码
1449601

神经技术设备的全球市场:按产品类型、按条件、按最终用户、按地区

Global Neurotech Devices Market, By Product Type, By Conditions, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年,全球神经技术设备市场价值为134.4亿美元,2024年至2031年的年复合成长率(CAGR)为13.5%,预计2031年将达到370.4亿美元。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 134.4亿美元
实际资料 2019-2023 预测期 2024-2031
预测期间 2023/2024 至 2030/2031 年复合年增长率: 13.50% 2030/2031价值预测 370.4亿美元
图 1. 2024 年神经技术设备的全球市场占有率(按地区划分)
全球神经科技设备市场-IMG1

神经技术设备旨在透过直接作用于神经系统来治疗各种神经系统疾病。这些创新技术利用植入或穿戴式感测器和刺激器来收集神经资料,并可能修復大脑和脊髓中受损的途径。传统治疗方法难以治疗的疾病,如阿兹海默症、帕金森氏症、癫痫和慢性疼痛,可能会受益于有针对性的神经调节方法。全球神经技术设备市场仍处于早期阶段,但随着新产品进入临床试验,正在迅速成长。先进材料和电子设备的小型化使得创建生物相容性神经介面成为可能。提高公众对神经系统疾病的认识以及增加政府对神经科学研究的支持是预计未来几年推动该市场持续扩张的一些关键因素。

市场动态:

神经技术设备市场的推动因素包括全球神经系统疾病盛行率的上升、神经介面技术的进步、对微创治疗的需求不断增长以及政府对神经科学研究的资助不断增加。然而,临床试验和产品开拓相关的高成本、新技术的报销挑战以及与长期设备植入相关的生物安全问题等因素对市场成长构成了重大挑战。此外,各种新兴企业和大公司开始探索神经技术在治疗之外的应用,例如增强认知等领域,这提供了利润丰厚的机会。研究人员、医疗设备公司和计算公司之间的合作将进一步加速下一代神经技术解决方案的开发。

本研究的主要特点

  • 该报告对全球神经技术设备市场进行了详细分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。
  • 它还说明了各个细分市场的潜在收益成长机会,并为该市场提供了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球神经技术设备市场的主要企业。
  • 该报告的见解将帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球神经技术设备市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 神经系统疾病发生率增加
    • 将人工智慧和物联网整合到神经技术设备中
    • 神经技术设备高成本
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • PEST分析
  • 波特的分析
  • 产品发表会
  • 合併、收购和合作

第四章全球神经技术设备市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第五章全球神经技术设备市场,依产品类型,2019-2031

  • 神经刺激
  • 神经刺激
  • 深部脑部刺激器
  • 胃电刺激设备
  • 脊髓刺激设备
  • 荐骨神经刺激器
  • 迷走神经刺激设备
  • 经皮神经电刺激 (TENS)
  • 其他神经刺激
  • 人工替代物
  • 神经感应
  • 神经復健装置

第六章 2019-2031 年全球神经技术设备市场(按情况)

  • 疼痛管理
  • 认知障碍
  • 癫痫
  • 尿失禁和大便失禁
  • 听力状况
  • 帕金森氏症
  • 忧郁症
  • 睡眠失调
  • 自发性震颤
  • 其他条件

第 7 章 全球神经技术设备市场,依最终使用者划分,2019-2031 年

  • 医院
  • 门诊手术中心
  • 居家护理设施
  • 其他最终用户

第八章全球神经技术设备市场(按地区),2019-2031

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 竞争格局

  • 公司简介
    • Boston Scientific Corporation
    • BrainCo, Inc
    • Cochlear Limited
    • Control Bionics, Inc
    • LivaNova PLC
    • Medtronic plc
    • Nihon Kohden Corporation
    • Natus medical Incorporated
    • Integra LifeSciences
    • Blackrock Microsystems
    • NeuroSigma, Inc.
    • NeuroVigil Inc.
    • Neuralink Corp.
    • Abbott Laboratories
    • Advanced Bionics AG

第10章

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6629

The global neurotech devices market was valued US$ 13.44 Bn in 2023 and is expected to reach US$ 37.04 Bn by 2031 growing at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 13.44 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 13.50% 2030/2031 Value Projection: US$ 37.04 Bn
Figure 1. Global Neurotech Devices Market Share (%), By Region, 2024
Global Neurotech Devices Market - IMG1

Neurotech devices aim to treat a variety of neurological disorders by interfacing directly with the nervous system. These innovative technologies utilize implantable or wearable sensors and stimulating devices to collect neural data and potentially repair damaged pathways in the brain or spinal cord. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain that have proved difficult to treat with conventional therapies may potentially benefit from targeted neuromodulation approaches. The global neurotech devices market is still at a nascent stage but growing rapidly as new products enter clinical trials. Advanced materials and miniaturization of electronics have enabled the creation of biocompatible neural interfaces. Rising public awareness about neurological illnesses and growing government support for neuroscience research are some of the key factors anticipated to drive continued expansion of this market in the coming years.

Market Dynamics:

The neurotech devices market is driven by the rising global prevalence of neurological disorders, technological advancements in neural interfaces, growing demand for minimally invasive therapies, and increasing government funding for neuroscience research. However, factors such as high costs associated with clinical trials and product development, reimbursement challenges for new technologies, and biosafety concerns pertaining to long term device implantation pose significant challenges to market growth. Various startups and large companies have also started exploring applications of neurotech beyond therapeutics, in areas like augmented cognition, which presents lucrative commercial opportunities. Collaborations between researchers, medical device firms, and computing companies are likely to further accelerate the development of next-generation neurotech solutions.

Key features of the study:

  • This report provides an in-depth analysis of the global neurotech devices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global neurotech devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Boston Scientific Corporation, BrainCo, Inc, Cochlear Limited, Control Bionics, Inc, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Natus medical Incorporated, Integra LifeSciences, Blackrock Microsystems, NeuroSigma, Inc., NeuroVigil Inc., Neuralink Corp., Abbott Laboratories, and Advanced Bionics AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global neurotech devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurotech devices market.

Detailed Segmentation:

  • Global Neurotech Devices Market, By Product Type
    • Neurostimulation
    • Deep brain stimulator
    • Gastric electric stimulator
    • Spinal cord stimulator
    • Sacral nerve stimulator
    • Vagus nerve stimulator
    • Transcutaneous electrical nerve stimulation (TENS)
    • Other neurostimulations
    • Neuroprostheses
    • Neurosensing
    • Neurorehabilitation devices
  • Global Neurotech Devices Market, By Conditions
    • Pain management
    • Cognitive disorders
    • Epilepsy
    • Urinary and fecal incontinence
    • Hearing conditions
    • Parkinson's disease
    • Depression
    • Sleep disorders
    • Essential tremor
    • Other conditions
  • Global Neurotech Devices Market, By End User
    • Hospitals
    • Ambulatory surgical centers
    • Homecare facilities
    • Other end users
  • Global Neurotech Devices Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in the Global Neurotech Devices Market:
    • Boston Scientific Corporation
    • BrainCo, Inc
    • Cochlear Limited
    • Control Bionics, Inc
    • LivaNova PLC
    • Medtronic plc
    • Nihon Kohden Corporation
    • Natus medical Incorporated
    • Integra LifeSciences
    • Blackrock Microsystems
    • NeuroSigma, Inc.
    • NeuroVigil Inc.
    • Neuralink Corp.
    • Abbott Laboratories
    • Advanced Bionics AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Conditions
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising incidence of neurological disorders
    • Integration of AI & IoT in neurotech devices
    • High cost of neurotech devices
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Neurotech Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Neurotech Devices Market, By Product Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Neurostimulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neurostimulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Deep brain stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Gastric electric stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Spinal cord stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Sacral nerve stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Vagus nerve stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Transcutaneous electrical nerve stimulation (TENS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other neurostimulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neuroprostheses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neurosensing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neurorehabilitation devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Neurotech Devices Market, By Conditions, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pain management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Cognitive disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Epilepsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Urinary and fecal incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Hearing conditions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Parkinson's disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Sleep disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Essential tremor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other conditions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Neurotech Devices Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Ambulatory surgical centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Homecare facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other end users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Neurotech Devices Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profile
    • Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • BrainCo, Inc
    • Cochlear Limited
    • Control Bionics, Inc
    • LivaNova PLC
    • Medtronic plc
    • Nihon Kohden Corporation
    • Natus medical Incorporated
    • Integra LifeSciences
    • Blackrock Microsystems
    • NeuroSigma, Inc.
    • NeuroVigil Inc.
    • Neuralink Corp.
    • Abbott Laboratories
    • Advanced Bionics AG

Analyst Views

10. Section

  • References
  • Research Methodology
  • About us